Vertex Pharmaceuticals Inc (VRTX)
471.12
-4.86
(-1.02%)
USD |
NASDAQ |
Nov 01, 16:00
471.00
-0.12
(-0.03%)
After-Hours: 20:00
Vertex Pharmaceuticals Shareholders Equity (Quarterly): 14.77B for June 30, 2024
Shareholders Equity (Quarterly) Chart
Historical Shareholders Equity (Quarterly) Data
Date | Value |
---|---|
June 30, 2024 | 14.77B |
March 31, 2024 | 18.55B |
December 31, 2023 | 17.58B |
September 30, 2023 | 16.51B |
June 30, 2023 | 15.47B |
March 31, 2023 | 14.43B |
December 31, 2022 | 13.91B |
September 30, 2022 | 13.03B |
June 30, 2022 | 11.93B |
March 31, 2022 | 10.91B |
December 31, 2021 | 10.10B |
September 30, 2021 | 9.531B |
June 30, 2021 | 9.196B |
March 31, 2021 | 8.980B |
December 31, 2020 | 8.687B |
September 30, 2020 | 8.133B |
June 30, 2020 | 7.519B |
March 31, 2020 | 6.462B |
December 31, 2019 | 6.085B |
September 30, 2019 | 5.253B |
June 30, 2019 | 5.070B |
March 31, 2019 | 4.723B |
December 31, 2018 | 4.435B |
September 30, 2018 | 2.906B |
June 30, 2018 | 2.686B |
Date | Value |
---|---|
March 31, 2018 | 2.401B |
December 31, 2017 | 2.029B |
September 30, 2017 | 1.791B |
June 30, 2017 | 1.671B |
March 31, 2017 | 1.500B |
December 31, 2016 | 1.157B |
September 30, 2016 | 1.022B |
June 30, 2016 | 981.35M |
March 31, 2016 | 957.08M |
December 31, 2015 | 939.97M |
September 30, 2015 | 922.15M |
June 30, 2015 | 894.96M |
March 31, 2015 | 976.46M |
December 31, 2014 | 1.075B |
September 30, 2014 | 1.156B |
June 30, 2014 | 1.172B |
March 31, 2014 | 1.231B |
December 31, 2013 | 1.356B |
September 30, 2013 | 1.265B |
June 30, 2013 | 1.322B |
March 31, 2013 | 746.12M |
December 31, 2012 | 999.18M |
September 30, 2012 | 1.028B |
June 30, 2012 | 1.038B |
March 31, 2012 | 930.50M |
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
6.085B
Minimum
Dec 2019
18.55B
Maximum
Mar 2024
11.67B
Average
10.91B
Median
Mar 2022
Shareholders Equity (Quarterly) Benchmarks
Eli Lilly and Co | 14.24B |
Bristol-Myers Squibb Co | 17.14B |
Regeneron Pharmaceuticals Inc | 29.33B |
Sarepta Therapeutics Inc | 1.077B |
Moderna Inc | 11.71B |
Shareholders Equity (Quarterly) Related Metrics
Total Assets (Quarterly) | 20.13B |
Total Liabilities (Quarterly) | 5.357B |
Current Ratio | 2.521 |